Parkinson's drug shortage in Argentina: Pfizer expects supply normalization in six months

Patients in Argentina report shortages of levodopa/carbidopa, a critical Parkinson's medication. Pfizer, the main supplier, confirmed manufacturing issues and estimates supply will normalize by March 2027. The shortage poses a public health risk for patients dependent on the drug, with uncertainty over interim supply.